Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helsinki Formula anti-baldness claims barred under FTC/Pantron settlement.

This article was originally published in The Tan Sheet

Executive Summary

HELSINKI FORMULA FTC SETTLEMENT: PANTRON LIQUIDATION PROCEEDS will be collected by the commission for a consumer redress program, according to a stipulated final judgment and permanent injunction filed in Los Angeles federal court Feb. 11 and announced by the Federal Trade Commission on Feb. 12. The settlement, which is not considered a fine or penalty, is intended to compensate purchasers of Pantron I's Helsinki Formula anti-baldness product and supports FTC's contention that Pantron made "false and deceptive" anti-baldness claims for Helsinki Formula.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086722

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel